# Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

Study · id `cardio:ct-nct05928936` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05928936](<https://clinicaltrials.gov/study/NCT05928936>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05928936

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 156 participants.

## Technical summary

Registry record NCT05928936. Randomized; quadruple masking; primary purpose basic science. Start 2022-11-11 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose basic science
- Phase: Phase 2
- Enrolled: 156 participants (planned count; ClinicalTrials.gov record NCT05928936, source copy `cardio:ctgov-nct05928936-2026-10-30`, retrieved 2026-10-31)
- Started: 2022-11-11 (actual) (ClinicalTrials.gov record NCT05928936, source copy `cardio:ctgov-nct05928936-2026-10-30`, retrieved 2026-10-31)
- Primary completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT05928936, source copy `cardio:ctgov-nct05928936-2026-10-30`, retrieved 2026-10-31)
- Completion: 2028-06-01 (anticipated) (ClinicalTrials.gov record NCT05928936, source copy `cardio:ctgov-nct05928936-2026-10-30`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05928936, source copy `cardio:ctgov-nct05928936-2026-10-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05928936-2026-10-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
- Condition: Chronic Kidney Disease
- Intervention (Drug): Sodium Bicarbonate
- Intervention (Behavioral): Exercise Training
- Intervention (Drug): Placebo
- Lead sponsor: Emory University
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Emory University (`cardio:org-emory-university`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: cba2778f0ed3cb621e6c38db425a672db165e00ca67a83f4acf002b82b49f789
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
